GSK1265744 (Cabotegravir) Mechanism of Action: HIV-1 Integrase Inhibition in CD4+ T Cells Research

GSK1265744 (Cabotegravir) MOA:Targeting HIV-1 Integrase/Viral DNA Integration Pathway for HIV Pre-Exposure Prophylaxis

🎯 check GSK1265744 (Cabotegravir) product page

GSK1265744 (Cabotegravir) is a potent HIV-1 integrase strand transfer inhibitor. It affects HIV-1 replication pathways by binding to the integrase catalytic domain and blocking the strand transfer step, effectively inhibiting viral DNA integration and HIV-1 infection.

Primary Applications and Mechanism of Action